Patents by Inventor Kristy L. Canavan
Kristy L. Canavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220206187Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.Type: ApplicationFiled: August 24, 2021Publication date: June 30, 2022Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Publication number: 20210379005Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. Anti-inflammatory lipid mediators can be selected from the group consisting of polyunsaturated fatty acids (e.g.Type: ApplicationFiled: August 20, 2021Publication date: December 9, 2021Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
-
Patent number: 11150383Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating unhydrated, polymerized ophthalmic lens with a polymeric wetting agent, wherein the ophthalmic lens formulation does not comprise said wetting agent prior to its polymerization.Type: GrantFiled: March 6, 2019Date of Patent: October 19, 2021Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Patent number: 11096919Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.Type: GrantFiled: July 2, 2019Date of Patent: August 24, 2021Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Annabelle Gallois-Bernos, Frank F. Molock, Jr., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
-
Publication number: 20200222357Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. Anti-inflammatory lipid mediators can be selected from the group consisting of polyunsaturated fatty acids (e.g.Type: ApplicationFiled: March 26, 2020Publication date: July 16, 2020Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
-
Publication number: 20190328698Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.Type: ApplicationFiled: July 2, 2019Publication date: October 31, 2019Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
-
Publication number: 20190317246Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.Type: ApplicationFiled: March 6, 2019Publication date: October 17, 2019Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Patent number: 10383839Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.Type: GrantFiled: June 13, 2012Date of Patent: August 20, 2019Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Annabelle Gallois-Bernos, Frank F. Molock, Jr., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
-
Patent number: 10267952Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating unhydrated, polymerized ophthalmic lens with a polymeric wetting agent, wherein the ophthalmic lens formulation does not comprise said wetting agent prior to its polymerization.Type: GrantFiled: June 7, 2016Date of Patent: April 23, 2019Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Publication number: 20160282518Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.Type: ApplicationFiled: June 7, 2016Publication date: September 29, 2016Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Patent number: 9395559Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating said ophthalmic lens with a wetting agent and packaging solution.Type: GrantFiled: March 4, 2014Date of Patent: July 19, 2016Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Publication number: 20150219928Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices. The ophthalmic devices are contacted with a wetting agent and heated to a temperature of at least about 50° C. to about 150° C.Type: ApplicationFiled: April 10, 2015Publication date: August 6, 2015Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie W. Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Patent number: 9052529Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices. The ophthalmic devices are contacted with a polyamide wetting agent and heated to a temperature of at least about 50° C. to about 150° C.Type: GrantFiled: March 15, 2013Date of Patent: June 9, 2015Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie W. Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Publication number: 20140185005Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.Type: ApplicationFiled: March 4, 2014Publication date: July 3, 2014Applicant: Johnson & Johnson Vision Care, Inc.Inventors: Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
-
Patent number: 8714738Abstract: The present invention relates to aqueous processes for the production of silicone hydrogel contact lenses.Type: GrantFiled: March 4, 2013Date of Patent: May 6, 2014Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Azaam Alli, Diana Zanini, James D. Ford, Shivkumar Mahadevan, Kristy L. Canavan, David C. Turner
-
Patent number: 8696115Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices by treating said ophthalmic lens with a wetting agent and packaging solution.Type: GrantFiled: October 4, 2010Date of Patent: April 15, 2014Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Kevin P. McCabe, Robert B. Steffen, Helene Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie W. Meyers, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill, Douglas G. Vanderlaan
-
Publication number: 20130005805Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.Type: ApplicationFiled: June 13, 2012Publication date: January 3, 2013Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
-
Publication number: 20110021656Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.Type: ApplicationFiled: October 4, 2010Publication date: January 27, 2011Inventors: Kevin P. McCabe, Robert B. Steffen, Helene Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie W. Meyers, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill, Douglas G. Vanderlaan
-
Patent number: 7841716Abstract: A method of providing a polymerized ophthalmic lens in which a polymerized ophthalmic lens is heated with a packaging solution comprising about 100 ppm to about 3,000 ppm of a wetting agent after its polymerization, and the ophthalmic lens formulation not having the wetting agent prior to its polymerization.Type: GrantFiled: February 10, 2006Date of Patent: November 30, 2010Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Kevin P. McCabe, Robert B. Steffen, Helene Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie W. Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill